Disruption of cotranscriptional splicing suggests RBM39 is a therapeutic target in acute lymphoblastic leukemia
| Autor: | Jin, Qi, Harris, Ethan, Myers, Jacquelyn A., Mehmood, Rashid, Cotton, Anitria, Shirnekhi, Hazheen K., Baggett, David W., Wen, Jeremy Qiang, Schild, Andrew B., Bhansali, Rahul S., Klein, Jonathon, Narina, Shilpa, Pieters, Tim, Yoshimi, Akihide, Pruett-Miller, Shondra M., Kriwacki, Richard, Abdel-Wahab, Omar, Malinge, Sebastien, Ntziachristos, Panagiotis, Obeng, Esther A., Crispino, John D. |
|---|---|
| Zdroj: | In Blood 5 December 2024 144(23):2417-2431 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|